Seres Therapeutics, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for MCRB, updated each market day.
MCRB AI Sentiment
AI sees no strong directional signal for Seres Therapeutics, Inc. stock over the next 10 market days.
Prediction date: Oct. 14, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Seres Therapeutics, Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Sector
Exchange
Market Cap
$26,417,774
Cap Tier
Employees
66
Headquarters
CAMBRIDGE, MA
Listed Since
June 26, 2015
MCRB Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
MCRB Volatility
Seres Therapeutics, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
